|
NAA35 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.27049490320042E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.32349686765565E-11 |
| Normal-vs-Stage2 |
4.619800E-04 |
| Normal-vs-Stage3 |
1.788930E-04 |
| Normal-vs-Stage4 |
2.1313999999939E-05 |
| Stage1-vs-Stage2 |
5.490200E-01 |
| Stage1-vs-Stage3 |
3.898200E-01 |
| Stage1-vs-Stage4 |
9.400200E-01 |
| Stage2-vs-Stage3 |
8.916400E-01 |
| Stage2-vs-Stage4 |
7.045600E-01 |
| Stage3-vs-Stage4 |
6.244800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.40700817452944E-12 |
| Normal-vs-AfricanAmerican |
1.7266999999821E-06 |
| Normal-vs-Asian |
4.21809999999745E-05 |
| Caucasian-vs-AfricanAmerican |
1.539360E-01 |
| Caucasian-vs-Asian |
6.109400E-01 |
| AfricanAmerican-vs-Asian |
3.328800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.93700611106351E-12 |
| Normal-vs-Female |
8.230500E-04 |
| Male-vs-Female |
6.834700E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.97900000004281E-06 |
| Normal-vs-Extreme_Weight |
1.73383529755711E-12 |
| Normal-vs-Obese |
5.35470000007088E-07 |
| Normal-vs-Extreme_Obese |
2.774300E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.051820E-01 |
| Normal_Weight-vs-Obese |
7.820600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.768800E-01 |
| Extreme_Weight-vs-Obese |
3.077900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.125400E-01 |
| Obese-vs-Extreme_Obese |
8.939400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.901500E-03 |
| Normal-vs-Age(41-60Yrs) |
1.43299999644242E-08 |
| Normal-vs-Age(61-80Yrs) |
4.69535521574471E-12 |
| Normal-vs-Age(81-100Yrs) |
4.01459998577991E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.832600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.497000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.394440E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.125700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.077760E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.585750E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.90079071874061E-12 |
| Normal-VS-Type2 PRCC |
8.76049999987139E-07 |
| Normal-VS-KIRP CIMP |
2.936400E-01 |
| Normal-VS-Unclassified PRCC |
6.96219999984926E-07 |
| Type1 PRCC-VS-Type2 PRCC |
2.298800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.493700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.131600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.652600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.462200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.203750E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.84249956905569E-10 |
| Normal-vs-N1 |
2.540500E-02 |
| Normal-vs-N2 |
1.796030E-04 |
| N0-vs-N1 |
1.104850E-01 |
| N0-vs-N2 |
5.979000E-01 |
| N1-vs-N2 |
2.955800E-01 |
|
|
